Saturday, 19 April 2014


NYOH is the region's leading provider of community-based cancer care services.

The physicians and staff of New York Oncology Hematology (NYOH) are committed to reducing the incidence of cancer and blood diseases through earlier detection and intervention and offering their patients the most appropriate, evidence-based treatment options. With seven convenient locations, including five comprehensive cancer centers, the NYOH network provides world-class care to thousands of patients every year -- right here, close to home! Through our affiliation with US Oncology, one of the nation's largest cancer research networks, NYOH has played a pivotal role in the FDA approval process of 24 new anticancer drugs. Our special approach to cancer care allows us to have the best minds working together. To develop new treatments. To achieve more cures. To bring the breakthroughs home, as they happen!

New Patients





NYOH Sponsors May 3rd Blood Cancer Conference


 Spring To Life EventNew York Oncology Hematology is sponsoring Spring to Life Conference on Hematologic Malignancies, the region’s first ever conference on blood cancers. It will be held at the Desmond Hotel, Albany, NY on Saturday, May 3, 2014 from 8:00 a.m. – 4:30 p.m.

NYOH has joined forces with Leukemia & Lymphoma Society and NMDP/Be the Match to host this one-day, CME-certified conference. Healthcare professionals and members of the community—including patients, survivors, family members and caregivers— are invited to attend.

Ira Zackon, MD, Director of the New York Oncology Hematology Stem Cell Transplant Program, is chairing the conference. He says it was launched to provide an up-to-date understanding of blood cancers, including state-of-the-art science behind treatment, clinical management, ongoing translational research, and emerging therapies. As important, sessions will also focus on the impact of these diseases on the lives of patients and families.


Click to learn more or register for the event